Dr. Joao Rezende-NetoFounder & Trauma Surgeon at St Michael's Hospital
Dr. Ori RotsteinFounder VP Research & Innovation at Unity Health Network
Chris BassFounder & CEO
Paul TorreggianiVP Business Development
Instructions for Use
Apply in minutes
Frequently Asked Questions
We saw positive patient impacts almost immediately once we began using the AbClo. In addition, we save considerable hard and soft costs and our physicians enjoyed using the AbClo device. Using the AbClo is not only improving our patient care but freeing up significant resources when we need them the most.
AbClo dramatically improved our closure rate for open abdomen patients. It was easy to use and was easily integrated into my current treatment methods for open abdomen patients. AbClo’s use resulted in better outcomes for my patients.
Closing open abdomens is critical because the risks associated with loss of domain are extremely serious. Almost 25% of patients who fail to achieve primary closure get fistulas and 40% of those patients die.
The current solutions for intentionally left open abdomens require invasive procedures which take significant time and are costly to implement. Mesh, anchoring systems and skin grafts are expensive to implement.
The pilot using the AbClo was extremely successful.
Our overarching vision has always been improving the lives of surgical teams and our patients.
AbClo allowed us to successfully close when we needed.